Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Agenesis of lung
Summary
Agenesis of lung is a rare congenital condition characterized by the complete absence of lung tissue on one side of the chest. This anomaly results from failed development of the lung bud during embryogenesis and may involve associated structural abnormalities, such as absence of the bronchus or pulmonary artery. The condition can impact respiratory function depending on the extent of the defect and the presence of compensatory mechanisms in the remaining lung.
Causes
Agenesis of lung arises from disruptions in early lung development during fetal growth. While specific causes are often not identifiable, genetic factors and environmental influences, such as maternal exposure to teratogens or infections, may contribute to the failure of lung bud formation. The exact mechanisms involve errors in branching morphogenesis or incomplete differentiation of lung tissue.
Risk Factors
- Family history of congenital lung or thoracic malformations.
- Maternal exposure to teratogens (e.g., certain medications, toxins) during pregnancy.
- Maternal infections affecting fetal lung development.
- Pre-existing maternal health conditions impacting fetal growth.
Symptoms
- Respiratory distress or difficulty breathing, especially in infancy.
- Recurrent respiratory infections.
- Asymmetric chest appearance or reduced breath sounds on the affected side.
- Cyanosis (bluish skin due to low oxygen) in severe cases.
- Possible associated anomalies (e.g., heart or skeletal defects).
Diagnosis
Prenatal ultrasound may detect lung agenesis during pregnancy. Postnatal diagnosis involves imaging studies such as chest X-rays, CT scans, or MRI to evaluate lung structure and associated abnormalities. Bronchoscopy or angiography may be used to assess airway and vascular development.
Treatment Options
Treatment focuses on managing respiratory symptoms and associated conditions. Supportive care includes oxygen therapy, respiratory support, and management of infections. Surgical intervention may be required for associated anomalies or to address complications. Long-term management depends on the severity of the defect and the function of the remaining lung.
Prognosis and Follow-Up
Prognosis varies based on the extent of the defect and the presence of other anomalies. Mild cases may have minimal impact on respiratory function, while severe cases can lead to chronic respiratory issues. Regular follow-up with a pulmonologist or pediatrician is recommended to monitor lung function and address complications.
Complications
- Chronic respiratory insufficiency.
- Recurrent pneumonia or respiratory infections.
- Associated congenital anomalies (e.g., heart defects).
- Reduced exercise tolerance due to limited lung capacity.
Lifestyle & Prevention
- Avoid exposure to tobacco smoke and environmental pollutants.
- Maintain good respiratory hygiene to reduce infection risk.
- Follow recommended vaccination schedules to prevent respiratory infections.
- Engage in regular physical activity as tolerated to support lung function.
When to Seek Professional Help
Seek immediate medical attention if experiencing severe respiratory distress, persistent cough, or signs of infection (e.g., fever, difficulty breathing). Regular check-ups are advised for monitoring lung function and addressing any new symptoms.
Tips for Medical Coders
Document the absence of lung tissue and any associated anomalies (e.g., bronchial or vascular defects) to support the diagnosis. Ensure clinical documentation specifies the side affected (left or right) and any related structural abnormalities. Code Q33.3 is specific to agenesis of lung and should be used when the condition is confirmed.
Medical Policies and Guidelines
Related policies from health plans
Q33.3 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.